mifepristone

AMA Update 296: Mifepristone and the future of reproductive health with Jack Resneck Jr., MD

With the legal challenge against mifepristone still making its way through the courts, AMA president Jack Resneck Jr., MD, joins to check in on the case and discuss what it could mean to patients, physicians and the future of medicine.

Find «Next steps in mifepristone court fight: What doctors should know», here: https://www.ama-assn.org/delivering-care/public-health/next-steps-mifepristone-court-fight-what-doctors-should-know

To read Dr. Resneck’s viewpoint «Judge’s ruling on mifepristone has no basis in medical science», visit: https://www.ama-assn.org/about/leadership/judge-s-ruling-mifepristone-has-no-basis-medical-science

Read More

AMA Update 293: Mifepristone, latest COVID variants, U.S. public health emergency ending with Andrea Garcia, JD, MPH

AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, shares what physicians and patients need to know about the end of the COVID-19 Public Health Emergency on May 11, 2023. Also covering the latest on abortion pill access, XBB.1.16 and XBB.1.9.1 trends, as well as a possible link between conjunctivitis and Arcturus variant. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 287: COVID-19, strep, STDs and Marburg cases on the rise with Andrea Garcia, JD, MPH

AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, covers the latest on coronavirus variant XBB.1.16 and FDA’s authorization changes for Moderna and Pfizer’s bivalent vaccines. Also discussing the rise of strep cases, increases in sexually transmitted diseases and infections. Plus what physicians and patients need to know about abortion pill rulings including the Biden Administrations emergency appeal along with Justice Samuel Alito issuing an administrative stay regarding mifepristone. American Medical Association CXO Todd Unger hosts.

Physicians can consult the American Academy of Pediatrics (AAP) guidance for alternative therapies during the shortage, here: https://www.aap.org/en/pages/amoxicillin-shortage-antibiotic-options-for-common-pediatric-conditions/

Read More

AMA Update 284: Mifepristone, Marburg virus, new COVID variant and RSV vaccine news with Andrea Garcia, JD, MPH

AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, covers the latest on the Marburg virus outbreak, new coronavirus variants XBB.1.16 and XBB.1.9.1, plus Pfizer’s RSV vaccine. Also discussing what physicians and patients need to know about Texas US District Judge Matthew Kacsmaryk’s ruling to suspend the FDA’s approval of mifepristone. American Medical Association CXO Todd Unger hosts.

Read More